Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors

NCT03261011 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
119
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akesobio Australia Pty Ltd